Fortune Brainstorm Tech 2026 Marks 25 Years of Tech Leadership in Aspen Japans Megabanks Record Profits Face Headwinds from Credit Costs and Geopolitical Risks US Prioritizes American AI Integration in Asia Following TrumpXi Meeting Says APEC Official SP 500 Edges Higher as Tech Surge Offsets Energy Slump Trump Maintains Iran Naval Blockade Signals No Rush for Deal White House Announces Soybean and Rare Earth Agreements Following TrumpXi Summit China Signals Tariff Reductions DMLP Q4 2024 Earnings EPS of 024 Reported Amid Stock Decline RM Q1 2026 Earnings EPS Surges Past Estimates as Regional Management Posts Strong Profit Beat LONA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Optimism LCTX Q1 2026 Earnings EPS Miss Weighs on Sentiment as ClinicalStage Biotech Continues Pipeline Progress Battalion Oil Corporation BATL Q2 2023 Earnings NarrowerThanExpected Loss Amid Continued Operational Challenges SOHOB Q2 2025 Earnings Preferred Dividend Coverage Holds Steady Amid Flat Stock Reaction Silence Therapeutics SLN Surges 71 Biotech Momentum Drives Price Above Support Title Virtus Total Return Fund ZTR Nears Support as Modest Decline Tests 676 Level Callan JMB Inc CJMB Edges Higher as Consolidation Near Support Continues Kezar Life Sciences KZR Holds Steady at 729 as Consolidation Persists PodcastOne Inc PODC Surges 667 Key Levels and Market Dynamics Bridgewater Associates Shifts Away from Enterprise SaaS Turns to AI Infrastructure and Semiconductors Kodiak AI Inc Q1 2026 Earnings EPS Surges Past Estimates Stock Slips on Revenue Uncertainty Permian Resources PR Holds Steady at 1932 as RangeBound Trading Continues BCAX Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline Paramount Gold Nevada Corp PZG Q1 2026 Earnings Major EPS Miss Stirs Investor Caution JKHY Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Uncertainty VLYPP Q1 2026 Earnings Preferred EPS Beats Estimates Stock Declines Slightly GTY Q1 2026 Earnings Strong EPS Surprise Drives Modest Stock Uptick SWKHL Q3 2025 Earnings Strong EPS Beat Driven by Portfolio Performance Evaxion Q1 2026 Earnings EPS Miss Weighs on PreRevenue Biotech Stock Edges Higher